Hydroxyapatite-coated total primary hip replacement: 28-year follow-up survivorship
HIP International · 2025
DOI: 10.1177/11207000241306004 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIP International, 2025. Verfasst von Manel Fa-Binefa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Hospital de Sant Pau (HSCSP), Barcelona, Spain. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Hip Prosthesis, Durapatite, Coated Materials, Biocompatible. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Survival at 25 years’ follow-up for total hip arthroplasty (THA) has been reported at 5%–77%, with hydroxyapatite (HA) coating, due to its osteo-conductive properties, used to enhance implant fixation and survival. The progressive increase in life expectancy raises doubts regarding HA-coated THA survival and THA revision surgery risk. The aim of our study was to retrospectively analyse survival for primary uncemented fully HA-coated THA after 28 years’ follow-up.
Methods
Our cohort survival study of the JRI Furlong HA-coated system retrospectively included patients aged 18–75 years who had undergone THA between 1992 and 1998 at our centre and who were followed up according to clinical records by orthopaedic surgeons to 2022. Data on THA revision surgery and its causes, follow-up, and death were analysed using Kaplan-Meier survival and Cox regression modelling.
Results
The cohort included 196 patients (268 hips) followed up to a maximum of 27.5 years (mean 15.54 (SD 6.01) years) with 62 patients (88 hips) >25 years. THA revision surgery was performed in 7.5% of cases, occurring a mean of 11.1 years following primary surgery. Aseptic loosening accounted for 4.4% of these revisions, affecting both the acetabular component (2.2%) and the femoral stem (1.3%). THA survival at 15 years’, 20 years’, and 27.5 years’ follow-up was 95.5%, 88.3%, and 79.3%, respectively. According to the log-rank and Cox regression analysis, no significant relationships were found.
Conclusions
Furlong HA-coated stem provides excellent long-term bone fixation for a long-term follow-up over 27.5 years with an aseptic loosening stem revision rate of 1.3%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Hospital de Sant Pau (HSCSP), Barcelona, Spain.
- Sant Pau Biomedical Research Institute (IIB Sant Pau), Barcelona, Spain.
- CIBER Epidemiology and Public Health (CIBERESP), Spain.
- Department of Clinical Epidemiology and Public Health, HSCSP, Barcelona, Spain.
ORCID-Profile: Manel Fa-Binefa
Zitieren
APA
Fa-Binefa, M., Serra, J., Moya, E., Crusi, X., Gich-Saladich, I., & Valera, M. (2025). Hydroxyapatite-coated total primary hip replacement: 28-year follow-up survivorship. HIP International. https://doi.org/10.1177/11207000241306004
Vancouver
Fa-Binefa M, Serra J, Moya E, Crusi X, Gich-Saladich I, Valera M. Hydroxyapatite-coated total primary hip replacement: 28-year follow-up survivorship. HIP International. 2025. doi:10.1177/11207000241306004
BibTeX
@article{FaBinefa2025,
author = {Fa-Binefa, Manel and Serra, Julia and Moya, Esther and Crusi, Xavier and Gich-Saladich, Ignasi and Valera, Marius},
title = {Hydroxyapatite-coated total primary hip replacement: 28-year follow-up survivorship},
journal = {HIP International},
year = {2025},
doi = {10.1177/11207000241306004}
}
EUVIMED